Suggestions
Nan Li
Founder @ Dimension
Nan Li is the Founder and Managing Partner at Dimension, a venture capital firm that focuses on investments at the intersection of life sciences and technology. Established in March 2022, Dimension aims to capitalize on the growing synergy between data science and biotech research. Under Li's leadership, the firm raised an impressive $350 million for its first fund, which was oversubscribed despite a challenging investment climate in the health sector during that period.12
Li has a robust background in venture capital and investment, having previously served as a Venture Partner and Managing Director at Obvious Ventures from 2015 to 2022. His investment experience includes roles at various companies such as Dyno Therapeutics, Octave, and Inato, where he has been involved in both investment and board advisory positions.13
He holds a Bachelor of Science in Computer Science from the University of Michigan, which underpins his expertise in the tech-driven aspects of modern biotech.1 Li's vision for Dimension includes fostering innovation in life sciences through collaboration with leading entrepreneurs and leveraging advancements in technology to enhance drug development processes.25
In addition to his professional endeavors, Nan Li is active on social media, where he shares insights related to his work and the evolving landscape of venture capital and biotechnology.46
Highlights
More on the @_DimensionCap co-led Series D for @Odyssey_Tx, one of the largest oversubscribed private rounds for therapeutics in 2025 (still possible!).
Incredible team, technology, pipeline, and translational data. 🚀🚀🚀
Excited to announce @_DimensionCap's partnership with @garydglick and the entire @Odyssey_Tx team on an oversubscribed Series D. They are moving ahead to an exciting chapter where the company will translate multiple programs out of a massively productive discovery platform.
Odyssey brings together novel biology, cutting-edge research tooling, and most importantly of all, a seasoned leadership team who have brought many drugs to patients.
Dimension continues to be believers in the productivity of discovery platforms and aims to partner with the best founders that want to build enduring companies in biotech. We are here to partner across all stages - from early company formation all the way through to IPO and beyond.
Onwards!!


